Vertex Pharmaceuticals (VX1) Q2 2023 Earnings Report
23 Followers
DE:VX1 Q2 2023 EPS Results
- Actual EPS
- EUR 3.47
- Consensus EPS
- EUR 3.44
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- EUR 3.21
DE:VX1 Q2 2023 Revenue Results
- Actual Revenue
- EUR 2.22B
- Expected Revenue
- EUR 2.16B
- Beat/Miss
- Beat by +EUR 57.43M
- YoY Revenue Growth
- +15.52%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/01/2023
- Time
- After Close
- Conference Call
- Tuesday, August 1, 2023
DE:VX1 Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:VX1 Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VX1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 3.77- | 4.49 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 4.304.25 | 4.28 | -0.83% (-0.04) | |
| Aug 03, 2026 | 2026 (Q2) | 4.234.22 | 4.03 | 4.65% (+0.19) | |
| May 04, 2026 | 2026 (Q1) | 3.783.99 | 3.62 | 10.10% (+0.37) | |
| Feb 12, 2026 | 2025 (Q4) | 4.564.49 | 3.55 | 26.38% (+0.94) | |
| Nov 03, 2025 | 2025 (Q3) | 4.084.28 | 3.91 | 9.59% (+0.37) | |
| Aug 06, 2025 | 2025 (Q2) | 3.834.03 | -11.45 | 135.23% (+15.48) | |
| May 05, 2025 | 2025 (Q1) | 3.853.62 | 4.25 | -14.71% (-0.62) | |
| Feb 10, 2025 | 2024 (Q4) | 3.583.55 | 3.75 | -5.24% (-0.20) | |
| Nov 04, 2024 | 2024 (Q3) | 3.643.91 | 3.64 | 7.35% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
